Quick Answer
Denali Therapeutics Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2025.
- This data is from Denali Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2023: $330.53 million | Fiscal year 2022: $105.07 million | Fiscal year 2021: $48.66 million | Fiscal year 2020: $335.56 million | Fiscal year 2019: $26.32 million | Fiscal year 2018: $129.10 million | Fiscal year 2017: $0.00 | Fiscal year 2016: $0.00.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: